Argus - Real-Time Stock Momentum Scanner

SCWorx (WORX) announced a new healthcare-system services agreement on October 19, but gave no contract value or expected revenue contribution.

Peraso Inc. (PRSO) announced a successful 60 GHz wireless connectivity demonstration with a humanoid robot; the update reports favorable test results, including approximately 500 Mbps uplink and 100 Mbps downlink.

NewGenIvf Group Limited disclosed a planned one-for-eight reverse stock split; the company says it is scheduled to take effect on October 23, not immediately.

GT Biopharma, Inc. (GTBP) registered up to 13,502,835 shares for resale in a prospectus filed on October 20, including shares issuable upon conversion of preferred stock and exercise of warrants; the company receives no proceeds from selling-stockholder resales. The company also disclosed substantial doubt about its ability to continue as a going concern, and a registration statement became effective on October 21.

Ping An Biomedical Co., Ltd. (PASW) shares are trading on the company's announcement of a 1-for-40 reverse stock split, effective October 23, expected to reduce its outstanding Class A and Class B shares substantially.

Alpha Modus (AMOD) shares are trading on the company’s announcement of a $7.25 million registered direct offering of 6,304,348 common shares at $1.15 per share. The company expects to use the net proceeds to repay certain indebtedness and for general corporate purposes.

Callan JMB (CJMB) announced blueprint approval for a planned IV bag facility in Marion, Alabama; the $450 million annual revenue figure is projected for once the facility is in production, not current revenue.

The proposed divestiture may be relevant to today’s trading: on October 19, Stratum Holdings Corp. (SRTM) announced a non-binding letter of intent to sell substantially all assets of its legacy real estate businesses, but disclosed no sale price or definitive agreement.

Shares are trading on INLIF Limited (INLF)’s announcement that it closed a registered direct offering, issuing shares and pre-funded warrants alongside additional warrants for approximately US$3.75 million in gross proceeds.

Kandal M Venture Limited (FMFC) disclosed that Nasdaq found it below the requirement for 500,000 publicly held shares; the company has until November 30 to submit a compliance plan. Nasdaq issued the notice on October 15, and the company disclosed it on October 20.

Shares are trading on Alpha Teknova, Inc.’s (TKNO) pricing of a public offering of 8 million newly issued common shares at $5.00 each, expected to raise $40 million in gross proceeds. Underwriters also have a 30-day option to buy up to 1.2 million additional shares.

Lakewood-Amedex Biotherapeutics (LABT) announced favorable Nu-3 laboratory findings ahead of its October 22 IDWeek presentation; the results describe laboratory testing, not clinical outcomes.

DarkIris Inc. (DKI) announced a 1-for-50 consolidation of its Class A and Class B ordinary shares, but it is scheduled to take effect at market open on October 22.

IM Cannabis Corp. (IMCC) has an effective registration statement that allows a shelf offering to proceed, but the SEC notice gives no offering size or terms.

Arcus Biosciences (RCUS) reported new ARC-20 data for investigational casdatifan across kidney cancer treatment settings; the update highlighted favorable results, including a 50% confirmed response rate in 30 first-line patients.